Analyzing the Hb levels into more detail, among the 367 STS patients, cancer-related death was diagnosed in 18 of 70 (25.7%) patients with low Hb levels and in 40 of 297 (13.5%) patients with high Hb levels (p<0.05). Here, GSTM1 is linked to cancer.